Effects of Cigarette Smoking on Heart Rate Variability and Plasma N-Terminal Pro-B-Type Natriuretic Peptide in Healthy Subjects: Is There the Relationship between Both Markers? (original) (raw)

2008, Annals of Noninvasive Electrocardiology

Abstract

Background: Cigarette smoking increased the risk of acute cardiac events related with endothelial dysfunction and increased sympathetic activity. Impaired autonomic nervous activity is recognized as a considerable symptom of cardiac dysfunction and is strongly associated with increased risk overall mortality. Methods: A total of 75 healthy habitual smokers (40 female, 35 male, mean age 36.5 ± 8.5 years), and 73 non-smokers subjects (45 female, 28 male, mean age 34.6 ± 7.2 years) were studied. LF and LF/HF ratio were significantly higher in smokers than in non-smokers. On the contrary, SDNN, SDANN, RMSSD, and HF values were lower in smokers compared to those in non-smokers. Not the duration of smoking but the number of cigarettes smoked per day was correlated with the HRV parameters and NT-pro BNP. Furthermore, the average levels of NT-pro BNP were found to be positively correlated with LF, LF/HF and inversely correlated with SDNN, SDANN, RMSSD and HF. Results: As a result, smoking impaires sympathovagal balance and decreases the heart rate variability in healthy subjects. And even a one cigarette smoking leads to overt sympathetic excitation. Furthermore, smoking results in an increase in NT-proBNP levels and the changes in adrenergic nervous system and NT-proBNP levels are well correlated. Conclusion: These findings could contribute to the higher rate of cardiovascular events in smokers.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (42)

  1. Hallstrom AP, Cobb LA, Ray R. Smoking as a risk fac- tor for recurrence of sudden cardiac arrest. N Engl J Med 1986;314:271-275.
  2. Celermajer DS, Sorensen KE, Georgeakopoulos D, et al. Cigarette smoking is associated with dose-related and po- tentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993;88:2149- 2155.
  3. Winniford MD, Weelan KR, Kremers MS, et al. Smoking- induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: Evidence for adren- ergically mediated alterations in coronary tone. Circulation 1986;73:662-667.
  4. Moliterno DJ, Willard JE, Lange RA, et al. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. N Engl J Med 1994;330:454-459.
  5. Grassi G, Seravalle G, Calhoun DA, et al. Mechanisms re- sponsible for sympathetic activation by cigarette smoking in humans. Circulation 1994;90:248-253.
  6. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysi- ology. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation 1996;93:1043-1065.
  7. Lopera GA, Huikuri HV, Makikallio TH, et al. Is abnormal heart rate variability a specific feature of congestive heart failure? Am J Cardiol 2001;87:1211-1213.
  8. Bilchick KC, Fetics B, Djoukeng R, et al. Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial of Antiarrhyhmic Ther- apy in Congestive Heart Failure). Am J Cardiol 2002;90: 24-28.
  9. Barutcu I, Esen AM, Kaya D, et al. Cigarette smoking and heart rate variability: Dynamic influence of parasympa- thetic and sympathetic maneuvers. A.N.E. 2005;10:324- 329.
  10. Hayano J, Yamada M, Sakakibara Y, et al. Short-and long- term effects of cigarette smoking on heart rate variability. Am J Cardiol 1990;65:84-88.
  11. Narkiewicz K, Van de Borne PJH, Hausberg M, et al. Cigarette smoking increases sympathetic outflow in hu- mans. Circulation 1998;98:528-534.
  12. Hausberg M, Mark Al, Winniford MD, et al. Sympathetic and vascular effects of short-term passive smoke exposure in healthy nonsmokers. Circulation 1997;96:282-287.
  13. Kobayashi F, Watanabe T, Akamatsu Y, et al. Acute ef- fects of cigarette smoking on the heart rate variability of taxi drivers during work. Scand J Work Environ Health 2005;31:360-366.
  14. Maisel AS, Mc Cullough PA. Cardiac natriuretic pep- tides: A proteomic window to cardiac function and clinical management. Rev Cardiovasc Med 2003;4 (Suppl. 4):S3- S12.
  15. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction. Comparison with Doppler velocity recordings. Circulation 2002;105:595-601.
  16. Pagani M, Lombardi F, Guzzetti S, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986;59:178-193.
  17. Malliani A, Pagani M, Lombardi F, et al. Advances in Re- search Series: Cardiovascular neural regulation explored in the frequency domain. Circulation 1991;84:482-492.
  18. Dekker JM, Crow RS, Folsom AR, et al. Low heart rate vari- ability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: The ARIC Study. Circulation 2000;102:1239-1244.
  19. Huikuri HV, Jokinen V, Syvanne M, et al. Heart rate vari- ability and progression of coronary atherosclerosis. Arte- rioscler Thromb Vasc Biol 1999;19:1979-1985.
  20. Wilhelm FH, Grossman P, Roth WT. Assessment of heart rate variability under non-stationary conditions: Com- plex demodulation vs. spectral analysis. Psychophysiology 1997;34 (Suppl. 1):S96.
  21. Robertson D, Tseng CJ, Appalsamy M. Smoking and mechanisms of cardiovascular control. Am Heart J 1988;115:258-263.
  22. Aronow WS, Dendinger J, Rokaw SN. Heart rate and car- bon monoxide level after smoking high-, low-, and non- nicotine cigarettes. A study in male patients with angina pectoris. Ann Intern Med 1971;74:697-702.
  23. Nadeau RA, James TN. Effects of nicotine on heart rate studied by direct perfusion of sinus node. Am J Physiol 1967;212:911-916.
  24. Mandel WJ, Laks M, Hayakawa H, et al. Cardiovascular effects of nicotine in the conscious dog. Modification by changes in autonomic tone. Am J Cardiol 1973;32:947-955.
  25. Kr üger C, Haunstetter A, Gerber S, et al. Nicotine-induced exocytotic norepinephrine release in guinea-pig heart, hu- man atrium and bovine adrenal chromaffin cells: Modula- tion by single components of ischaemia. J Mol Cell Cardiol 1995;27:1491-1506.
  26. Manica G, Groppelli A, Di Rienzo M, et al. Smoking impairs baroreflex sensitivity in humans.
  27. Failla M, Grappiolo A, Carugo S, et al. Effects of cigarette smoking on carotid and arterial distensibility. J Hypertens 1997;15:1659-1664.
  28. Cryer PE, Haymond MW, Santiago JV, et al. Nore- pinephrine release and adrenergic mediation of smoking- associated hemodynamic and metabolic events. N Engl J Med 1976;295:573-577.
  29. Hill P, Wynder EL. Smoking and cardiovascular disease. Effect of nicotine on the serum epinephrine and corticoids. Am Heart J 1974;87:491-496.
  30. Minami J, Ishimitsu T, Matsuoka H. Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension 1999;33 (1 Pt 2):586-590.
  31. Yotsukura M, Koide Y, Fujii K, et al. Heart rate variability during the first month of smoking cessation. Am Heart J 1998;135 (6 Pt 1):1004-1009.
  32. Ragueneau I, Michaud P, Demolis JL, et al. Effects of cigarette smoking on short-term variability of blood pres- sure in smoking and non smoking healthy volunteers. Fun- dam Clin Pharmacol 1999;13:501-507.
  33. Groppelli A, Giorgi D, Omboni S, et al. Persistent blood pressure increase induced by heavy smoking. J Hypertens 1992;10:495-499.
  34. Mair J, Hammerer-Lercher A, Puschendorf B. The im- pact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Physiol 1998;18:185-201.
  35. Groenning BA, Nilsson JC, Sondergaard L, et al. Detection of left ventricular enlargement and impaired systolic func- tion with plasma N-terminal pro brain natriuretic peptide concentrations. Am Heart J 2002;143:923-929.
  36. Alam M, Samad BA, Wardell J, et al. Acute effects of smok- ing on diastolic function in healthy participants: Studies by conventional Doppler echocardiography and Doppler tis- sue imaging. J Am Soc Echocardiogr 2002;15:1232-1237.
  37. Stork T, Danne O, Muller R, et al. Effect of smoking on re- laxation and filling behavior of the left ventricle in healthy probands. An echocardiography study Med Klein. (Munich) 1991;15;86:173-179.
  38. Kim HK, Bae JW, Chung JW, et al. Differences in immedi- ate effects of smoking on left ventricular diastolic function between healthy volunteers and patients with type 2 dia- betes mellitus. J Am Soc Echocardiogr 2005;18:320-325.
  39. Arteaga E, Araujo AQ, Buck P, et al. Plasma amino- terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy. Am Heart J 2005;150:1228- 1232.
  40. Abramson BL, Ando S, Notarius CF, et al. Effect of atrial natriuretic peptide on muscle sympathetic activity and its reflex control in human heart failure. Circulation 1999;99(14):1810-1815.
  41. Butler GC, Senn BL, Floras JS. Influence of atrial natriuretic factor on heart rate variability in normal men. Am J Physiol 1994;267(2 Pt 2):H500-H505.
  42. Brunner-La Rocca HP, Kaye DM, et al. Effects of intra- venous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as com- pared with healthy control subjects. J Am Coll Cardiol 2001;37(5):1221-1227.